These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Butters TD; Dwek RA; Platt FM Glycobiology; 2005 Oct; 15(10):43R-52R. PubMed ID: 15901676 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the biochemistry and genetics of sphingolipidoses. Ozkara HA Brain Dev; 2004 Dec; 26(8):497-505. PubMed ID: 15533650 [TBL] [Abstract][Full Text] [Related]
9. An appraisal of human trials in enzyme replacement therapy of genetic diseases. Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527 [No Abstract] [Full Text] [Related]
11. National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model. Kesselman I; Elstein D; Israeli A; Chertkoff R; Zimran A Blood Cells Mol Dis; 2006; 37(1):46-9. PubMed ID: 16824774 [TBL] [Abstract][Full Text] [Related]
12. Molecular facets of sphingolipids: mediators of diseases. Ozbayraktar FB; Ulgen KO Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220 [TBL] [Abstract][Full Text] [Related]
13. Musculoskeletal complications encountered in the lysosomal storage disorders. Pastores GM Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):937-47. PubMed ID: 19028373 [TBL] [Abstract][Full Text] [Related]
14. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565 [TBL] [Abstract][Full Text] [Related]
19. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease. Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778 [TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease. Fujiwaki T; Tasaka M; Yamaguchi S J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):170-6. PubMed ID: 18502707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]